Language
DEEN
Market analysis··2 min read

GLP-1 Medicines Reshaping Retail

The increasing use of GLP-1 medications for weight loss is beginning to influence the retail sector, as consumption habits and demand profiles shift.

AI generatedGLP-1 Medicines Reshaping Retail – AI-generated illustrative image
GLP-1 Medicines Reshaping Retail. Illustrative image generated using artificial intelligence (AI). The image does not depict a real property, person or event and is not a documentary photograph. Labelled in accordance with Article 50(4) of the EU AI Act.

According to a Gallup poll, only 3 per cent of adults in the US were using GLP-1 medications for weight loss in 2024. By July 2026, this proportion rose to 11 per cent, and 15 per cent reported having tried a GLP-1 medication like Ozempic or Wegovy for weight loss at some point. This development indicates a significant shift in consumer behaviour, which could have far-reaching implications for various sectors, particularly retail.

Experts are observing these trends with great interest, as a changed physical constitution of the population leads not only to health but also to economic shifts. The direct impacts on the food and beverage industry are already noticeable, as users of these medications often report reduced appetite and altered preferences. This could long-term lead to a realignment of offerings in the food retail sector.

Shift in Consumer Behaviour

Weight loss through GLP-1 medications typically involves a diminished craving for certain foods, especially sugary and fatty products. This could compel supermarkets and restaurants to reconsider their assortments and menus. Furthermore, there are potential impacts on the clothing trade, as a declining average clothing size could affect demand for specific sizes and fits.

Moreover, it is expected that the changes in body weight induced by GLP-1 medications will go beyond the purely physical aspect, leading to psychological effects that, in turn, influence purchasing behaviour. If people feel more comfortable in their bodies, they might gravitate towards new leisure activities or social engagements, which would then boost demand for corresponding products and services in retail and beyond.

Implications for the Property Market

For FREITAG® Immobilien, these developments are significant, as they influence the valuation and development of retail spaces. Shopping centres and high-street locations must adapt to changing consumer needs. This could mean increased demand for spaces for services, healthcare offerings, or specialised food shops, while traditional fast-food concepts or businesses that rely heavily on impulse purchases may need to make adjustments. The demographic shifts, brought about by the wider use of GLP-1 medications, necessitate careful analysis and strategic planning for investments in the retail sector. Proactive adaptation to these new market dynamics will be crucial for the sustainable success of property projects.

  • Analysis of tenant demand in retail properties for new concepts.
  • Assessment of potential for health and wellness providers within commercial properties.
  • Cross-sector consideration of food and clothing retailers.
  • Strategic planning for a changing consumer base in urban centres.

Looking for
a real estate
agent?

Michael Freitag — founder of FREITAG® Immobilien
Michael Freitag
Founder of FREITAG® Immobilien GmbH
More than 15 years of experience in Bavaria & surroundings
— FREITAG Immobilien

Your discreet partner for institutional transactions in German-speaking Europe.

As a premium real estate firm based in Munich we advise investors, family offices, developers and long-term holders on the acquisition, sale and valuation of residential, income and commercial properties — confidential, close to the market and on equal terms.

3.600+
municipalities on our market radar
48 h
first assessment of your property
Off-market
discreet circle of buyers
DACH
DE · AT · CH
— Confidential contact

Let us talk about your portfolio.

Acquisition profiles, off-market opportunities, valuations or development enquiries — we reply personally within 24 hours, NDA as a matter of course.

Phone
+49 (0) 89 158 90 140
Email
E-Mail anzeigen
Office
Munich
More news
Most read in the journal